The US immunoassays market is expanding on the back of rising demand for early disease detection, a growing burden of chronic and infectious diseases, and continued advances in diagnostic technologies. A well-established healthcare infrastructure and strong investment in medical research are supporting wider adoption of immunoassay-based testing across hospitals, diagnostic laboratories, and...